To investigate the potential participation of SLC16A1-AS1 in BC carcinogenesis and development, we first investigated the lncRNA expression pattern based on public BC (BRCA) databases (TCGA dataset) by the online tool GEPIA, which showed a significantly lower SLC16A1-AS1 expression in tumor (T, n = 1,085) tissues than in normal (N, n = 291) tissues of BC (BRCA) patients (Figure 1A). The gene discussed is SLC16A1; the disease is neoplasm.